FDA clears first digital treatment for depression, but experts caution research is still early

Rejoyn is an app intended for use alongside antidepressant medications for people with major depressive disorder.

Related Keywords

United States ,American ,Brian Iacoviello ,John Kraus ,John Torous ,Drug Administration ,Cnn ,Otsuka Pharmaceutical ,Click Therapeutics ,Emotional Faces Memory Task ,Digital Psychiatry ,Beth Israel Deaconess Medical Center ,Medicine ,Sychology ,Natomy ,Harmacology ,Ob Market ,Software ,Rade ,Sychiatry ,Business ,Computer Science ,